Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // December 16th, 2009 // 7:01 am
Rise and shine, everyone, another day has begun. And as the Morning Mayor used to say, every brand new day should be unwrapped like a precious gift. As you can tell, we like comforting thoughts. So as you unwrap your proverbial ribbon, we have assembled a few items to help you along. Whatever you do today, we hope you accomplish your goals. Catch you later…
Sanofi Buys Rights To Syntiron’s MRSA Vaccine (Bloomberg News)
USPTO OKs Alnylam, Isis RNAi Claims (OutsourcingPharma)
Roche Licenses Pain Treatment To Afferent (MarketWatch)
FDA Panel Backs Wider Use Of AstraZeneca’s Crestor (Reuters)
Biogen Threatens Proxy Fight For Facet (San Diego Business Journal)
Sanofi’s Dehecq To Be Replaced By Weinberg (Bloomberg News)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Afferent, AstraZeneca, Biogen Idec, Crestor, Facet Biotech, Roche, Sanofi Aventis